Prima BioMed Ltd (PBMD.OQ)

PBMD.OQ on NASDAQ Stock Exchange Global Market

0.95USD
25 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
$0.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,617
52-wk High
$1.94
52-wk Low
$0.91

PBMD.OQ

Chart for PBMD.OQ

About

Prima BioMed Ltd is a biotechnology company is engaged in the research, development and commercialization of licensed medical biotechnology. The Company focuses on the the development of personalized immunocellular therapeutic products for the treatment of cancer. The Company’s lead product is CVac is an autologous dendritic... (more)

Overall

Beta: 1.81
Market Cap (Mil.): $45.77
Shares Outstanding (Mil.): 1,271.46
Dividend: --
Yield (%): --

Financials

  PBMD.OQ Industry Sector
P/E (TTM): -- 228.31 39.03
EPS (TTM): -0.01 -- --
ROI: -51.46 -2.22 17.31
ROE: -51.48 -3.38 18.22
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks